ScholarWorks@Korea University

Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

SARS-CoV-2 Breakthrough Infections after Introduction of 4 COVID-19 Vaccines, South Korea, 2021

Full metadata record
DC Field Value Language
dc.contributor.authorYi, Seonju-
dc.contributor.authorChoe, Young June-
dc.contributor.authorKim, Jia-
dc.contributor.authorKim, Yoo-Yeon-
dc.contributor.authorKim, Ryu Kyung-
dc.contributor.authorJang, Eun Jung-
dc.contributor.authorLim, Do Sang-
dc.contributor.authorByeon, Hye Ryeon-
dc.contributor.authorLee, Sangwon-
dc.contributor.authorPark, Eonjoo-
dc.contributor.authorKim, Seung-Jin-
dc.contributor.authorPark, Young-Joon-
dc.date.accessioned2022-04-12T06:42:51Z-
dc.date.available2022-04-12T06:42:51Z-
dc.date.created2022-04-12-
dc.date.issued2022-03-
dc.identifier.issn1080-6040-
dc.identifier.urihttps://scholar.korea.ac.kr/handle/2021.sw.korea/140096-
dc.description.abstractWe conducted a nationwide retrospective cohort study to estimate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infection among recipients of 4 different vaccines in South Korea. Age-adjusted breakthrough infection rate per month was highest for Janssen (42.6/100,000 population), followed by AstraZeneca (21.7/100,000 population), Pfizer-BioNTech (8.5/100,000 population), and Moderna (1.8/100,000 population).-
dc.languageEnglish-
dc.language.isoen-
dc.publisherCENTERS DISEASE CONTROL & PREVENTION-
dc.subjectVACCINATION-
dc.titleSARS-CoV-2 Breakthrough Infections after Introduction of 4 COVID-19 Vaccines, South Korea, 2021-
dc.typeArticle-
dc.contributor.affiliatedAuthorChoe, Young June-
dc.identifier.doi10.3201/eid2803.212210-
dc.identifier.scopusid2-s2.0-85125332800-
dc.identifier.wosid000771729200036-
dc.identifier.bibliographicCitationEMERGING INFECTIOUS DISEASES, v.28, no.3, pp.753 - 756-
dc.relation.isPartOfEMERGING INFECTIOUS DISEASES-
dc.citation.titleEMERGING INFECTIOUS DISEASES-
dc.citation.volume28-
dc.citation.number3-
dc.citation.startPage753-
dc.citation.endPage756-
dc.type.rimsART-
dc.type.docTypeLetter-
dc.description.journalClass1-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaImmunology-
dc.relation.journalResearchAreaInfectious Diseases-
dc.relation.journalWebOfScienceCategoryImmunology-
dc.relation.journalWebOfScienceCategoryInfectious Diseases-
dc.subject.keywordPlusVACCINATION-
Files in This Item
There are no files associated with this item.
Appears in
Collections
ETC > 1. Journal Articles
Show simple item record

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

STATISTICS
Total View :8,730,657
Today View :13,571

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(02841) 서울특별시 성북구 안암로 14502-3290-1114

COPYRIGHT © 2021 Korea University. All Rights Reserved.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

English